Reversine-treated fibroblasts acquire myogenic competence in vitro and in regenerating skeletal muscle

Luigi Anastasia, Maurilio Sampaolesi, Nadia Papini, Diego Oleari, Giuseppe Lamorte, Cristina Tringali, Eugenio Monti, Daniela Galli, Guido Tettamanti, Giulio Cossu, Bruno Venerando

Research output: Contribution to journalArticle

65 Citations (Scopus)

Abstract

Stem cells hold a great potential for the regeneration of damaged tissues in cardiovascular or musculoskeletal diseases. Unfortunately, problems such as limited availability, control of cell fate, and allograft rejection need to be addressed before therapeutic applications may become feasible. Generation of multipotent progenitors from adult differentiated cells could be a very attractive alternative to the limited in vitro self-renewal of several types of stem cells. In this direction, a recently synthesized unnatural purine, named reversine, has been proposed to induce reversion of adult cells to a multipotent state, which could be then converted into other cell types under appropriate stimuli. Our study suggests that reversine treatment transforms primary murine and human dermal fibroblasts into myogenic-competent cells both in vitro and in vivo. Moreover, this is the first study to demonstrate that plasticity changes arise in primary mouse and human cells following reversine exposure.

Original languageEnglish
Pages (from-to)2042-2051
Number of pages10
JournalCell Death and Differentiation
Volume13
Issue number12
DOIs
Publication statusPublished - Dec 2006

Fingerprint

Mental Competency
Skeletal Muscle
Fibroblasts
Musculoskeletal Diseases
Allografts
In Vitro Techniques
2-(4-morpholinoanilino)-6-cyclohexylaminopurine
Regeneration
Cardiovascular Diseases
Stem Cells
Skin

ASJC Scopus subject areas

  • Cell Biology

Cite this

Reversine-treated fibroblasts acquire myogenic competence in vitro and in regenerating skeletal muscle. / Anastasia, Luigi; Sampaolesi, Maurilio; Papini, Nadia; Oleari, Diego; Lamorte, Giuseppe; Tringali, Cristina; Monti, Eugenio; Galli, Daniela; Tettamanti, Guido; Cossu, Giulio; Venerando, Bruno.

In: Cell Death and Differentiation, Vol. 13, No. 12, 12.2006, p. 2042-2051.

Research output: Contribution to journalArticle

Anastasia, L, Sampaolesi, M, Papini, N, Oleari, D, Lamorte, G, Tringali, C, Monti, E, Galli, D, Tettamanti, G, Cossu, G & Venerando, B 2006, 'Reversine-treated fibroblasts acquire myogenic competence in vitro and in regenerating skeletal muscle', Cell Death and Differentiation, vol. 13, no. 12, pp. 2042-2051. https://doi.org/10.1038/sj.cdd.4401958
Anastasia, Luigi ; Sampaolesi, Maurilio ; Papini, Nadia ; Oleari, Diego ; Lamorte, Giuseppe ; Tringali, Cristina ; Monti, Eugenio ; Galli, Daniela ; Tettamanti, Guido ; Cossu, Giulio ; Venerando, Bruno. / Reversine-treated fibroblasts acquire myogenic competence in vitro and in regenerating skeletal muscle. In: Cell Death and Differentiation. 2006 ; Vol. 13, No. 12. pp. 2042-2051.
@article{f179bed0b3f849fea12bab38a0767503,
title = "Reversine-treated fibroblasts acquire myogenic competence in vitro and in regenerating skeletal muscle",
abstract = "Stem cells hold a great potential for the regeneration of damaged tissues in cardiovascular or musculoskeletal diseases. Unfortunately, problems such as limited availability, control of cell fate, and allograft rejection need to be addressed before therapeutic applications may become feasible. Generation of multipotent progenitors from adult differentiated cells could be a very attractive alternative to the limited in vitro self-renewal of several types of stem cells. In this direction, a recently synthesized unnatural purine, named reversine, has been proposed to induce reversion of adult cells to a multipotent state, which could be then converted into other cell types under appropriate stimuli. Our study suggests that reversine treatment transforms primary murine and human dermal fibroblasts into myogenic-competent cells both in vitro and in vivo. Moreover, this is the first study to demonstrate that plasticity changes arise in primary mouse and human cells following reversine exposure.",
author = "Luigi Anastasia and Maurilio Sampaolesi and Nadia Papini and Diego Oleari and Giuseppe Lamorte and Cristina Tringali and Eugenio Monti and Daniela Galli and Guido Tettamanti and Giulio Cossu and Bruno Venerando",
year = "2006",
month = "12",
doi = "10.1038/sj.cdd.4401958",
language = "English",
volume = "13",
pages = "2042--2051",
journal = "Cell Death and Differentiation",
issn = "1350-9047",
publisher = "Nature Publishing Group",
number = "12",

}

TY - JOUR

T1 - Reversine-treated fibroblasts acquire myogenic competence in vitro and in regenerating skeletal muscle

AU - Anastasia, Luigi

AU - Sampaolesi, Maurilio

AU - Papini, Nadia

AU - Oleari, Diego

AU - Lamorte, Giuseppe

AU - Tringali, Cristina

AU - Monti, Eugenio

AU - Galli, Daniela

AU - Tettamanti, Guido

AU - Cossu, Giulio

AU - Venerando, Bruno

PY - 2006/12

Y1 - 2006/12

N2 - Stem cells hold a great potential for the regeneration of damaged tissues in cardiovascular or musculoskeletal diseases. Unfortunately, problems such as limited availability, control of cell fate, and allograft rejection need to be addressed before therapeutic applications may become feasible. Generation of multipotent progenitors from adult differentiated cells could be a very attractive alternative to the limited in vitro self-renewal of several types of stem cells. In this direction, a recently synthesized unnatural purine, named reversine, has been proposed to induce reversion of adult cells to a multipotent state, which could be then converted into other cell types under appropriate stimuli. Our study suggests that reversine treatment transforms primary murine and human dermal fibroblasts into myogenic-competent cells both in vitro and in vivo. Moreover, this is the first study to demonstrate that plasticity changes arise in primary mouse and human cells following reversine exposure.

AB - Stem cells hold a great potential for the regeneration of damaged tissues in cardiovascular or musculoskeletal diseases. Unfortunately, problems such as limited availability, control of cell fate, and allograft rejection need to be addressed before therapeutic applications may become feasible. Generation of multipotent progenitors from adult differentiated cells could be a very attractive alternative to the limited in vitro self-renewal of several types of stem cells. In this direction, a recently synthesized unnatural purine, named reversine, has been proposed to induce reversion of adult cells to a multipotent state, which could be then converted into other cell types under appropriate stimuli. Our study suggests that reversine treatment transforms primary murine and human dermal fibroblasts into myogenic-competent cells both in vitro and in vivo. Moreover, this is the first study to demonstrate that plasticity changes arise in primary mouse and human cells following reversine exposure.

UR - http://www.scopus.com/inward/record.url?scp=33751018547&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33751018547&partnerID=8YFLogxK

U2 - 10.1038/sj.cdd.4401958

DO - 10.1038/sj.cdd.4401958

M3 - Article

C2 - 16729034

AN - SCOPUS:33751018547

VL - 13

SP - 2042

EP - 2051

JO - Cell Death and Differentiation

JF - Cell Death and Differentiation

SN - 1350-9047

IS - 12

ER -